The 50% PWT was calculated via the updown method
Diabetes should be well-managed before starting therapy Active pituitary tumors: Stimulating a gland with an active tumor is contraindicated Monitoring Requirements Safe use of CJC-1295/Ipamorelin requires ongoing physician monitoring: Baseline labs: IGF-1, fasting glucose, HbA1c, thorough metabolic panel, CBC 4-6 week follow-up: IGF-1 to confirm dose response
WADA classifies all forms of IGF-1 and their analogues under the S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics category, prohibited both in-competition and out-of-competition [21]
As shown in Figure S8A, it appears that low-level GliT expression is evident throughout mycelia without gliotoxin addition
After age 30, growth hormone production declines by approximately 14% per decade